End-Of-Life Costs in U.S.: Not So High?

Watch out for the limitations before taking too much comfort

An article this week in the Journal of the American Medical Association indicated that in-hospital deaths among cancer patients were lower, and end-of-life costs no higher, in the U.S. than in some other industrialized nations. Sounds reassuring, but in this 150-second analysis, MedPage Today medical reviewer F. Perry Wilson, MD, points up several caveats that undercut the feel-good messages.

F. Perry Wilson, MD, is an assistant professor of medicine at the Yale School of Medicine. He earned his BA from Harvard University, graduating with honors with a degree in biochemistry. He then attended Columbia College of Physicians and Surgeons in New York City. From there he moved to Philadelphia to complete his internal medicine residency and nephrology fellowship at the Hospital of the University of Pennsylvania. During his post graduate years, he also obtained a Master of Science in Clinical Epidemiology from the University of Pennsylvania. He is an accomplished author of many scientific articles and holds several NIH grants. He is a MedPage Today reviewer, and in addition to his video analyses, he authors a blog, The Methods Man. You can follow @methodsmanmd on Twitter.

Accessibility Statement

At MedPage Today, we are committed to ensuring that individuals with disabilities can access all of the content offered by MedPage Today through our website and other properties. If you are having trouble accessing www.medpagetoday.com, MedPageToday's mobile apps, please email legal@ziffdavis.com for assistance. Please put "ADA Inquiry" in the subject line of your email.